28 related articles for article (PubMed ID: 31353381)
1. Cellular Delivery of Nanoparticles Revealed with Combined Optical and Isotopic Nanoscopy.
Proetto MT; Anderton CR; Hu D; Szymanski CJ; Zhu Z; Patterson JP; Kammeyer JK; Nilewski LG; Rush AM; Bell NC; Evans JE; Orr G; Howell SB; Gianneschi NC
ACS Nano; 2016 Apr; 10(4):4046-54. PubMed ID: 27022832
[TBL] [Abstract][Full Text] [Related]
2. Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review.
Alemzadeh E; Allahqoli L; Mazidimoradi A; Alemzadeh E; Ghasemi F; Salehiniya H; Alkatout I
Oncol Res; 2024; 32(5):831-847. PubMed ID: 38686048
[TBL] [Abstract][Full Text] [Related]
3. Lipophilic Fe(III)-Complex with Potent Broad-Spectrum Anticancer Activity and Ability to Overcome Pt Resistance in A2780cis Cancer Cells.
Abeydeera N; Stilgenbauer M; Pant BD; Mudarmah K; Dassanayake TM; Zheng YR; Huang SD
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446578
[TBL] [Abstract][Full Text] [Related]
4. Supramolecular platinum complexes for cancer therapy.
Jogadi W; Zheng YR
Curr Opin Chem Biol; 2023 Apr; 73():102276. PubMed ID: 36878171
[TBL] [Abstract][Full Text] [Related]
5. Inter-Organelle Contact Sites Mediate the Intracellular Antioxidant Activity of Platinum Nanozymes: A New Perspective on Cell-Nanoparticle Interaction and Signaling.
Migliaccio V; Blal N; De Girolamo M; Mastronardi V; Catalano F; Di Gregorio I; Lionetti L; Pompa PP; Guarnieri D
ACS Appl Mater Interfaces; 2023 Jan; 15(3):3882-3893. PubMed ID: 36629473
[TBL] [Abstract][Full Text] [Related]
6. Polymer-Based Nanosystems-A Versatile Delivery Approach.
Niculescu AG; Grumezescu AM
Materials (Basel); 2021 Nov; 14(22):. PubMed ID: 34832213
[TBL] [Abstract][Full Text] [Related]
7. The Application of Biomaterials in the Treatment of Platinum-Resistant Ovarian Cancer.
Levy A; Leynes C; Baig M; Chew SA
ChemMedChem; 2019 Nov; 14(21):1810-1827. PubMed ID: 31456347
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review.
Binju M; Padilla MA; Singomat T; Kaur P; Suryo Rahmanto Y; Cohen PA; Yu Y
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):371-378. PubMed ID: 30423357
[TBL] [Abstract][Full Text] [Related]
9. New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.
Hyeraci M; Scalcon V; Folda A; Labella L; Marchetti F; Samaritani S; Rigobello MP; Dalla Via L
ChemMedChem; 2021 Jun; 16(12):1956-1966. PubMed ID: 33751814
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
Qin X; Fang L; Chen F; Gou S
Eur J Med Chem; 2017 Sep; 137():167-175. PubMed ID: 28586717
[TBL] [Abstract][Full Text] [Related]
11. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
Yu H; Gou S; Wang Z; Chen F; Fang L
Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity of [{Cis-PtCl(NH3)2}2µ{trans-Pt(3-Hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in the human ovarian tumour models.
Hamad SA; Beale P; Yu JQ; Fisher K; Huq F
Med Chem; 2012 May; 8(3):384-91. PubMed ID: 22530892
[TBL] [Abstract][Full Text] [Related]
14. Dual-action organoplatinum polymeric nanoparticles overcoming drug resistance in ovarian cancer.
Jayawardhana AMDS; Qiu Z; Kempf S; Wang H; Miterko M; Bowers DJ; Zheng YR
Dalton Trans; 2019 Sep; 48(33):12451-12458. PubMed ID: 31353381
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
